Analyst Reco. agilon health, inc.

Equities

AGL

US00857U1079

Market Closed - Nyse Other stock markets 16:00:02 2024-05-02 EDT			5-day change	1st Jan Change
4.83 ^USD	-2.62%		-5.85%	-61.51%

04-22	Citigroup Starts agilon health With Neutral Rating, $6 Price Target	MT
03-06	Barclays Initiates Agilon Health With Underweight Rating, Price Target is $5	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Citigroup Starts agilon health With Neutral Rating, $6 Price Target	04-22	MT
Barclays Initiates Agilon Health With Underweight Rating, Price Target is $5	03-06	MT
Deutsche Bank Cuts Agilon Health's Price Target to $8 From $10, Maintains Hold Rating	02-29	MT
Truist Securities Cuts Price Target on Agilon Health to $7.50 From $10, Maintains Hold Rating	02-29	MT
RBC Cuts Price Target on Agilon Health to $8 From $11, Says Near Term 'Could Remain Choppy,' Keeps Outperform Rating	02-28	MT
TD Cowen Downgrades Agilon Health to Market Perform From Outperform	02-26	MT
Deutsche Bank Adjusts Price Target on Agilon Health to $10 From $12, Maintains Hold Rating	01-08	MT
Wolfe Research Downgrades Agilon Health to Peer Perform From Outperform	01-08	MT
JPMorgan Downgrades Agilon Health to Neutral From Overweight, Cuts Price Target to $9 From $17	01-05	MT
Goldman Sachs Downgrades Agilon Health to Neutral From Buy, Cuts Price Target to $14 From $22	12-11	MT
JMP Securities Initiates Agilon Health With Market Outperform Rating, Price Target is $18	12-06	MT
Deutsche Bank Downgrades Agilon Health to Hold From Buy, Adjusts Price Target to $12 From $27	11-21	MT
Benchmark Adjusts agilon health's Price Target to $22 From $28, Keeps Buy Rating	11-15	MT
Wells Fargo Adjusts agilon health's Price Target to $16 From $23, Keeps Overweight Rating	11-13	MT
Goldman Sachs Cuts Price Target on agilon health to $22 From $25, Maintains Buy Rating	11-09	MT
RBC Cuts Price Target on agilon health to $23 From $28, Keeps Outperform Rating	11-03	MT
TD Cowen Adjusts agilon health's Price Target to $25 From $29, Keeps Outperform Rating	23-08-15	MT
Goldman Sachs Adjusts Price Target on agilon health to $25 From $29, Maintains Buy Rating	23-08-15	MT
RBC Cuts Price Target on agilon health to $28 From $33, Maintains Outperform Rating	23-07-19	MT
Truist Securities Adjusts Price Target on agilon health to $27 From $35, Maintains Buy Rating	23-06-20	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. agilon health, inc.

Equities

AGL

US00857U1079

Analyst Reco.

Filters